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Patients with complex congenital heart disease are at risk for neurodevelopmental impairments. Evidence suggests that brain
maturation can be delayed and pre- and postoperative brain injury may occur, and there is limited information on the long-term
effect of congenital heart disease on brain development and function in adolescent patients. At a mean age of 13.8 years, 39
adolescent survivors of childhood cardiopulmonary bypass surgery with no structural brain lesions evident through conventional
cerebral magnetic resonance imaging and 32 healthy control subjects underwent extensive neurodevelopmental assessment
and cerebral magnetic resonance imaging. Cerebral scans were analysed quantitatively using surface-based and voxel-based
morphometry. Compared with control subjects, patients had lower total brain (P = 0.003), white matter (P = 0.004) and cortical
grey matter (P = 0.005) volumes, whereas cerebrospinal fluid volumes were not different. Regional brain volume reduction
ranged from 5.3% (cortical grey matter) to 11% (corpus callosum). Adolescents with cyanotic heart disease showed more
brain volume loss than those with acyanotic heart disease, particularly in the white matter, thalami, hippocampi and corpus
callosum (all P-values50.05). Brain volume reduction correlated significantly with cognitive, motor and executive functions
(grey matter: P50.05, white matter: P50.01). Our findings suggest that there are long-lasting cerebral changes in adolescent
survivors of cardiopulmonary bypass surgery for congenital heart disease and that these changes are associated with functional
outcome.
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Introduction
Severe congenital heart disease (CHD) requiring surgical interven-
tion occurs in 6 of 1000 live-born infants (Hoffman and Kaplan,
2002). Although substantial improvements in surgical treatment
and perioperative care have led to excellent cardiac outcomes
and consecutively a significant increase in survival rates, impair-
ments of neurodevelopmental and behavioural outcome have
been described for school age and early adolescence (Bellinger
et al., 2003, 2011; von Rhein et al., 2011). The population of
adolescent and adult patients with CHD is increasing, and it is
therefore of importance to identify potential non-cardiac sequelae
in this population.
The high rate of neurodevelopmental impairments in patients
with CHD, including cognitive and motor deficits, and difficulties
with daily living skills, communication or adaptive behaviour
(Bellinger et al., 2003; Hovels-Gurich et al., 2006; Majnemer
et al., 2008; Snookes et al., 2010; von Rhein et al., 2011) has
prompted foetal and neonatal cerebral neuroimaging studies to
elucidate the underlying causes of brain injury. They have demon-
strated delayed brain maturation in infants with severe CHD, fea-
turing delays in myelination and cortical folding as well as
abnormal brain metabolism and microstructure (Miller et al.,
2007; Licht et al., 2009; Limperopoulos et al., 2010). In addition,
preoperative brain injury, consisting mostly of white matter
changes, can be seen in up to 50% of patients (Mahle et al.,
2002; McQuillen et al., 2007; Miller et al., 2007). New postopera-
tive lesions comparable to the ones seen in preterm-born infants
have been described in 30% of infants in a regional distribution
(Mahle et al., 2002; McQuillen et al., 2007). Recently, structural
brain lesions have also been reported in adolescents after cardio-
pulmonary bypass surgery for CHD (Bellinger et al., 2011; von
Rhein et al., 2011), showing predominantly focal white matter
abnormalities and white matter volume reduction.
Importantly, the relationship between neuroimaging findings
and neurodevelopmental impairments has not yet been estab-
lished. Brain volume reduction has been quantified for young chil-
dren with CHD (Watanabe et al., 2009), and a weak relationship
has been found between frontal grey matter volume and early
motor development (Watanabe et al., 2009). On the other
hand, a variety of studies demonstrated regional brain volume
reductions in the cerebellum, hippocampus and corpus callosum,
which were associated with cognitive and perceptual functions in
former preterm-born adolescents (Martinussen et al., 2009; Taylor
et al., 2011). Thus, in patients with CHD, the functional relevance
of imaging findings in relation to neurodevelopmental outcome
needs to be established. As structural MRI findings (Bellinger
et al., 2011; von Rhein et al., 2011) have been correlated with
functional outcomes in adolescent survivors of CHD, a correlation
between total and regional brain volumes and functional out-
comes, similarly to findings in preterm adolescents, would be ex-
pected. Furthermore, results regarding cyanosis as a risk factor for
adverse neurodevelopmental outcome are controversial.
Thus, the aims of our study were to (i) investigate whether brain
morphometric measurements (global and regional brain volumes,
cortical thickness and surface area) are reduced in adolescents with
corrected CHD; (ii) to examine the relationship between quantita-
tive brain measurements and functional outcome. We hypothe-
sized that we would find primarily reduced white matter
volumes. We further hypothesized associations between reduced
white matter and deficits in cognitive performance; and (iii) we
aimed to identify risk factors for volume reductions in adolescent
heart patients without overt brain lesions, and specifically exam-
ined whether the type of CHD (cyanotic versus acyanotic) was
associated with poorer functional and structural outcome.
Materials and methods
Participants
Participants had undergone cardiac surgery for different types of CHD
with full flow cardiopulmonary bypass at the University Children’s
Hospital Zurich between 1995 and 1998 (median age at first surgery:
0.9 years; range 0–5.6 years). Children with a diagnosis of known or
suspected chromosomal and genetic syndromes or a neurological co-
morbidity were excluded (Landolt et al., 2008). Of 117 adolescent
patients who took part in a previous follow-up study in 2004–05
(Landolt et al., 2008), we excluded those with an age of 17 years
or older at the time of this study, those wearing braces, pacemakers,
or cochlear implants, and those who had reported claustrophobia.
Twenty-three of the 78 eligible adolescents refused participation,
and two were lost to follow-up. Hence, 53 adolescents with CHD
(median age 13.8 years, range 11.4–16.9, 46% male) were assessed.
Demographic and surgical characteristics were not significantly differ-
ent between participants and patients lost to follow-up. Nevertheless,
the participants of this study represented a subgroup with fewer
neurological abnormalities (33% versus 60%, P5 0.001) and better
cognitive functioning at 10 years of age (IQ at 10 years: 93.2  18.4
versus 86.1  14.1, P = 0.02) compared to those lost to follow-up. As
described previously, cerebral imaging abnormalities were detected in
11 of 53 patients (21%) and in none of the control subjects
(von Rhein et al., 2011). The 11 patients with imaging abnormalities
were excluded from the morphometric analyses. Neurodevelopmental
outcome of the excluded individuals was poorer than those of patients
without brain lesions (von Rhein et al., 2011). In three patients, mor-
phometric analyses could not be performed due to movement arte-
facts. Therefore, morphometric measures were performed in 39
patients (surface based analysis, see Supplementary Table 2). Results
were compared to 32 healthy control subjects (median age 13.9 years,
range 9–16.9; 41% male) who either were enrolled for this study
(n = 11) or who had participated as controls in another study
(n = 21). All went to regular school and none suffered any chronic
or neurological diseases. Controls had no brain lesions visible on
MRI. Groups were not significantly different with regards to sex and
socioeconomic status and underwent identical neurodevelopmental
assessment.
Neurodevelopmental assessment
Neurodevelopmental assessment included a standardized neurological
examination, the Zurich Neuromotor Assessment, the Wechsler
Intelligence Scale for Children fourth edition, the Beery Test of
visuo-motor integration, and the Rey-Osterrieth Complex Figure
Test. Neurodevelopmental assessment was performed before the
MRI examination by an experienced paediatric neurologist (M.vR)
who was aware of the medical condition but not the imaging results.
Congenital heart disease in adolescents Brain 2014: 137; 268–276 | 269
Image acquisition
Brain MRI was performed with a 3.0 T whole-body system
(SignaTwinspeedHD.xt, GE Healthcare). Three-dimensional high reso-
lution anatomical images of the entire brain were obtained using an
inversion-recovery prepared T1-weighted spoiled gradient echo pulse
sequence (repetition time = 25 ms; echo time = 5 ms, inversion
time = 450 ms, flip angle = 13, field of view = 24 cm, acquisition
matrix = 352  224, slice thickness 1.2 mm, image resolution
0.47  0.47 mm) and an axial T2-weighted fast spin echo pulse se-
quence (repetition time = 6660 ms; echo time = 97.6 ms; field of
view = 24 cm, acquisition matrix = 512  384, slice thickness 3 mm,
image resolution 0.47  0.47 mm). Anatomical evaluation was per-
formed by an experienced neuroradiologist (I.S.) who was blinded to
the participants’ medical history. The 3D T1-weighted spoiled gradient
echo whole brain images were also used for morphometric assessment.
Post-processing
Surface-based analysis
All images were transformed into Analyze format and entered into a
standard morphometric analysis using Freesurfer version 4.5.0 for
Macintosh computers (http://surfer.nmr.mgh.harvard.edu). This soft-
ware calculates subcortical volumes and cortical areas and thicknesses.
The cortical stream tessellates each hemisphere on the grey–white
border and allows the measurement of cortical thicknesses at each
point of the tessellation. In addition, the volumes and cortical thick-
nesses of many individual gyri and sulci can be measured. The total
brain volume was calculated as the sum of the grey and white matter
volumes of the cortical hemispheres, callosal and subcortical volumes
(including cerebellum), and the volumes of the inner and outer CSF
compartments. For further statistical analyses, cortical and subcortical
volumes were pooled over the left and right hemisphere structures.
Additionally, a voxel-based morphometry analysis was conducted,
involving a segmentation into grey matter white matter, CSF and
three classes of non-brain tissue with the ‘new segment’ function.
These segmented maps were warped into a common space using a
diffeomorphic transformation (Dartel tools implemented in SPM8;
http://www.fil.ion.ucl.ac.uk/spm/software/spm8). Then, each native
T1-weighted image was warped using these segmentation maps in
an attempt to minimize distortions because of differences of the pa-
tient and children’s brains to the template and to thereby maximize
sensitivity. Initial segmentation was successful in 44 participants. The
others had lower image quality and were discarded from further ana-
lysis. This complementary analysis allowed visualization of the exact
locations of the volumetric changes and detection of finer differences
within subcortical structures than those found in the global and sur-
face-based analyses. Sex, age and total brain volumes were always
linearly regressed out as control variables of no interest.
Statistics
All behavioural and Freesurfer data were analysed using PASW stat-
istics software [PASW (SPSS) statistics 18.0, IBM]. Comparisons of
study groups were controlled for sex and age at the time of the
scan. To determine the associations between brain volume and neu-
rodevelopmental performance, regression analyses with cognitive and
motor test scores as dependent variables were conducted for total
brain volume and total grey and white matter volumes. To determine
the independent association between regional brain volumes and func-
tional outcome, multiple stepwise linear regression models were
performed, each including total brain volume and the brain regions
that were significantly reduced on bivariate analysis (total cortical grey
matter, white matter, volumes of cerebellum, hippocampi and corpus
callosum) as well as sex and age at scan. Additionally, we performed
stepwise linear regression analyses including total brain volume and
the lobal surface areas of the cortical lobes as well as sex and age
at scan to investigate any lobe-specific associations with functional
outcome. All regression analyses were performed separately for pa-
tients and controls. We used P-values of 0.05 and 0.10 to enter or
remove variables, respectively.
Finally, multiple regression analyses were calculated to identify risk
factors for volume reduction in the heart patient group. For each po-
tential risk factor (type of heart disease, cyanosis, duration of heart
surgery, extracorporeal circulation time, aortic cross-clamp time, length
of intensive care unit stay, length of hospital stay), a separate regres-
sion model was performed including sex, age at scan, and total brain
volume as further independent variables.
Ethical approval was obtained from the Ethics Committee at the
University Children’s Hospital and written informed consent was ob-
tained from the parent or primary caregivers and from the adolescents.
Results
Patient characteristics
Medical characteristics of the patient group are provided in
Supplementary Table 1. Neurodevelopmental performance was
poorer in patients with CHD than in control subjects, reaching stat-
istical significance in 7 of 15 domains (Supplementary Table 2).
No significant difference in outcome was found between patients
with cyanotic and acyanotic CHD (data not shown). Former pre-
term-born patients with CHD showed no significant differences in
neurodevelopmental outcome and brain volumes compared to
former term-born CHD patients (Mann-Whitney U-test, data not
shown).
Morphometric results
Patients after surgery for CHD had smaller total brain volumes,
total white matter, and cortical and deep grey matter volumes
than control subjects, whereas ventricular volumes were not dif-
ferent (Table 1). Total grey matter reduction was more pro-
nounced in the limbic cortex, frontal and parietal lobes, and
cerebellum. White matter reduction did not show any specific re-
gional predilection (Fig. 1). T-tests for all available cortical lobes
showed no significant differences in cortical thickness between
patients and controls. Group differences in regional volumes
mostly disappeared when correcting for total brain volume (data
not shown). We found a significant positive correlation between
white matter volume and age at scan (beta = 0.30, P50.001,
controlled for total brain volume) in the CHD patient group, but
not in the control group (Fig. 2). Total brain volume and grey
matter volumes did not correlate significantly with age in either
group. Cortical thickness was negatively correlated with age in the
congenital heart patient group (mean thickness of all sulci and
gyri: R2 = 0.52, P = 0.001, prefrontal cortices: R2 = 0.50,
P = 0.001, occipital lobes: R2 = 0.39, P = 0.02), whereas no
such correlations were found in the control group.
270 | Brain 2014: 137; 268–276 M. von Rhein et al.
In a separate analysis, we compared brain volumes of patients in
our cohort with those patients with overt cerebral lesions who had
been excluded from the main analyses. No significant differences
were detected between these groups.
Risk factors
All brain volumes were smaller in patients with cyanotic CHD than
in those with acyanotic CHD, reaching significant levels (P5 0.05)
for white matter, thalami, hippocampi and corpus callosum vol-
umes. Furthermore, patients with acyanotic heart disease had
smaller cortical grey matter, cerebellum, basal ganglia and hippo-
campal volumes than control subjects (Table 2). Stepwise logistic
regression analyses showed that cyanotic CHD was an independ-
ent predictor of callosal (beta = 0.35, P = 0.01) and hippocampal
size (beta = 0.21, P = 0.04) in patients, even when entering total
brain volume, age and sex (corpus callosum: beta = 0.38,
P = 0.006, hippocampi: beta = 0.71, P5 0.001, respectively) into
the equation. No other risk factor (socioeconomic status, duration
or number of surgeries, length of hospital stay, or postoperative
EEG or neurological abnormalities) correlated with morphometric
measures.
Correlation between brain volumes and
functional outcome
Figure 3 shows the significant correlations between total brain
volume and IQ in patients with CHD. Significant correlations
were also found between total brain volume and other cognitive
function measures (verbal comprehension: beta = 0.41, P = 0.01,
perceptual reasoning: beta = 0.36, P = 0.04, working memory:
beta = 0.34, P = 0.04) and static balance (beta = 0.36, P = 0.03)
independent of disease severity (cyanotic or acyanotic). In control
subjects, no association was found between total brain volume
and functional outcome.
When analysing the impact of specific brain regions on neuro-
developmental outcome within the patient group, stepwise regres-
sion analyses (adjusted for socioeconomic status, sex, age at
assessment and total brain volume) showed that hippocampal
volume was related to total IQ and perceptual reasoning. Total
white matter volume correlated with verbal comprehension and
motor performance, and cerebellar volume correlated with work-
ing memory and static balance (Table 3). In the control group,
hippocampal volume correlated with perceptual reasoning index
(R2 = 0.12, beta = 0.38, P = 0.04), corpus callosum volume with
processing speed (R2 = 0.20, beta = 0.48, P = 0.007), and cere-
bellar volume with fine motor performance (R2 = 0.16,
beta = 0.44, P = 0.02). No significant correlation with functional
outcome was found with respect to the surface areas of the cor-
tical lobes. Head circumference was smaller in patients [53.4 cm,
standard deviation (SD) 2.0] than in control subjects (55.6 cm, SD
1.5; P = 0.01), but did not correlate with neurodevelopmental out-
come in either group.
Discussion
In our population of adolescents operated for CHD without overt
structural brain lesions, we found a global brain volume reduction
affecting both grey and white matter. Further, there was no
region-specific volume reduction after correction for total brain
volume. Brain volumes correlated with functional outcome in ado-
lescents with CHD, but not in control subjects. Cyanotic CHD was
a risk factor for smaller brain volumes. Importantly, functionally
relevant brain volume reductions were also detected in patients
without overt structural brain abnormalities. This highlights the
importance of quantitative imaging measurements in this popula-
tion. As a significant number of patients with CHD show brain
alterations at least until adolescence, this population needs not
only long-term specialized cardiac care but also structured neuro-
psychological assessments.
Distribution of brain volume reduction
We previously reported structural imaging findings for this patient
cohort, which included white matter lesions and signs of previous
arterial stroke (von Rhein et al., 2011). We could confirm our
hypothesis that brain volumes were significantly reduced in pa-
tients without overt lesions compared with control subjects. The
white matter volume was particularly affected, which corresponds
to the predominant white matter structural injury pattern in ado-
lescents with CHD (Bellinger et al., 2011; von Rhein et al., 2011).
In addition, neonatal magnetic resonance studies have shown al-
terations predominantly in the white matter, similar to the injury
pattern found in preterm-born infants (Childs et al., 2001; Miller
Table 1 Global and regional brain volumes in patients and
controls
Controls,
n = 32
Patients,
n = 39
%
Reduction
mean (SD) mean (SD)
Total brain volume 1216 (112) 1130 (120) 7.0*
White matter volume 434 (47) 397 (55) 8.5**
Cortical grey matter volume 570 (63) 532 (51) 5.3**
Ventricular volume 13.23 (4.91) 13.85 (6.29)
Volume gyri total 379 (41) 354 (36) 6.6**
Volume sulci total 190 (22) 174 (19) 8.4**
Surface area gyri total 1165 (129) 1078 (115) 7.5**
Surface area sulci total 828 (96) 765 (90) 7.6**
Thickness gyri total 2.69 (0.11) 2.69 (0.10) 0
Thickness sulci total 2.40 (0.09) 2.41 (0.07) 0
Surface area frontal lobes 351 (49.7) 326 (39.7) 7.1*
Surface area temporal lobes 327 (46.2) 301 (38.8) 7.9**
Surface area parietal lobes 216 (24.4) 202 (24.0) 6.5**
Surface area occipital lobes 83 (12.9) 78 (9.5) 6
Surface area limbic cortices/
mesocortices
111 (12.4) 100 (9.9) 9.9***
Volume cerebellum 145 (14.1) 136 (12.2) 6.2**
Volume thalami 14.4 (1.2) 13.7 (1.6) 4.9*
Volume basal ganglia 24.5 (1.8) 22.8 (2.5) 6.9**
Volume hippocampi 8.2 (0.8) 7.5 (0.7) 8.5***
Volume corpus callosum 3.09 (0.39) 2.75 (0.47) 11.0***
Results of surface-based morphometry, reduction in % (controls = 100%), P:
t-test for means, brain volumes in cm3, surface areas in cm2, thickness in mm;
*P5 0.05, **P50.01, ***P50.001.
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Figure 1 Colour brain maps (axial plains) expressing the differences between the regional brain volumes of patients with CHD and
controls; P50.001. Colours represent T-values (corrected for age and sex). (A) White matter; (B) grey matter.
Table 2 Comparison of brain volumes between patients with acyanotic and cyanotic CHD and control subjects
Controls n = 32 Acyanotic heart
disease n = 20
P-value: controls
versus acyanotic
Cyanotic heart
disease n = 19
P-value: acyanotic
versus cyanotic
Mean (SD) Mean (SD) Mean (SD)
Total brain volume 1216 (112) 1168 (125) 1108 (101)
White matter volume 434 (47) 418 (63) 377 (47) 50.05
Cortical grey matter volume 570 (63) 539 (58) 50.05 526 (46)
Ventricular volume 13.23 (4.91) 13.10 (4.48) 14,35 (6.75)
Surface area gyri total 1165 (129) 1115 (116) 1059 (104)
Surface area sulci total 828 (96) 798 (95) 744 (69)
Thickness gyri total 2.69 (0.10) 2.68 (0.11) 2.72 (0.12)
Thickness sulci total 2.41 (0.07) 2.39 (0.09) 2.42 (0.09)
Surface area frontal lobes 351 (50) 337 (44) 322 (34)
Surface area temporal lobes 327 (46) 316 (45) 284 (30) 50.05
Surface area parietal lobes 216 (24) 208 (23) 194 (24)
Surface area occipital lobes 83 (13) 79 (9) 77 (9)
Surface area limbic cortices/
mesocortices
111 (12.4) 102 (11) 50.01 98 (9)
Volume cerebellum 145 (14.1) 137 (13.1) 50.01 136 (11.4)
Volume thalami 14.4 (1.2) 14.3 (1.7) 13.0 (1.2) 50.05
Volume basal ganglia 24.5 (1.8) 23.1 (2.5) 50.05 23.0 (2.4)
Volume hippocampi 8.2 (0.8) 7.9 (0.8) 50.05 7.2 (0.6) 50.05
Volume corpus callosum 3.09 (0.39) 2.97 (0.29) 2.56 (0.41) 50.01
Results of surface-based morphometry, P: t-test for means of controls and acyanotic, and acyanotic versus cyanotic heart disease: brain volumes in cm3, surface areas in
cm2, thickness in mm.
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et al., 2007; Licht et al., 2009; Limperopoulos et al., 2010). Only
one study so far has demonstrated grey matter volume reduction
at the age of 15 months (Watanabe et al., 2009). The combin-
ation of grey and white matter volume reductions in our sample
may reflect a combination of the late sequelae of delayed intra-
uterine brain maturation, as well as acquired perioperative brain
injury. In contrast to the global volume changes in our cohort,
(Ortinau et al., 2012a, b) found a more regional brain size reduc-
tion in infants with CHD before surgery, but a normal brain
growth at 3 months of age after surgical repair. These findings
could indicate an undisturbed myelination at this early age.
Interestingly, in our sample, patients with CHD showed a positive
correlation between age and total white matter volume. This may
suggest an ongoing white matter development in patients that
could not be detected in controls despite similar ages at scanning.
These findings may indicate that patients with CHD undergo a
longer maturation period because of a delay in white matter mat-
uration. Longitudinal data would be needed to prove this
hypothesis.
We found a normal cortical thickness but reduced cortical sur-
face areas, which was roughly proportional to the number of cor-
tical columns and closely related to the number of radial glia.
Assuming a constant number of connections for each cortical
column, this would imply a strongly reduced number of axons,
which could explain the widespread reduction in white matter
volume. Conversely, a reduced cortical surface could also be a
result of axonal loss due to white matter injury or delayed devel-
opment. We mainly found reduced grey matter volumes in pa-
tients with acyanotic CHD compared with controls, although
cyanotic patients also showed a decrease in white matter
volume. This observation accounts for both superficial and deep
grey and white matter structures. It seems logical that the thalami,
which also contain white matter, follow the pattern of the cortical
white matter and corpus callosum in this respect. The subcortical
cores, which interact closely with the cortical columns, show a
reduction that resembles the reduction of the cortical surface in
effect size. Studies in preterm neonates have shown subcortical
changes in this population, which have been attributed to im-
paired oxygen supply. Subcortical regions and white matter are
generally considered important for cognitive and motor functions,
so the widespread distribution of volume differences in our pa-
tients with CHD could lead to a functional sum effect of all regions
involved (cortical and subcortical regions and white matter). In
patients with CHD, delayed brain maturation at term, along
Figure 2 Scatterplots of white matter volumes plotted versus age (separately for patients and controls). Linear regression curves of
(A) patients (R2 = 0.36, P = 0.05) and (B) controls (R2 = 0.05, P = 0.82).
Table 3 Reduced brain volumes in association with
neurodevelopmental outcome in patients
Predictor Corrected
R2
Beta P-value
Cognitive abilities
Total IQ Hippocampal volume 0.18 0.45 0.004
Verbal comprehension Total white matter 0.17 0.44 0.006
Perceptual reasoning Hippocampal volume 0.11 0.36 0.03
Working memory Cerebellar volume 0.16 0.42 0.008
Processing speed
Motor abilities
Pure motor Total white matter 0.15 0.41 0.01
Adaptive fine motor
Dynamic balance
Static balance Cerebellar volume 0.11 0.36 0.03
Stepwise linear regression analyses (dependent variable: functional outcomes).
Variables included in each model: volumes of total brain tissue, white matter,
cortical grey matter, cerebellum, corpus callosum, and hippocampus, sex and age
at scan.
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with early acquired white matter lesions secondary to cardiopul-
monary bypass surgery, could cause further alterations in brain
development with impacts on both white and grey matter struc-
tures, leading to the widespread brain volume reduction observed
in our adolescent patients. This mechanism has been shown
by neuroimaging studies in former preterm-born adolescents
(de Kieviet et al., 2012).
Interestingly, brain volumes in the excluded patients with cere-
bral lesions were not different from those without overt lesions.
This suggests mechanisms that independently involve the entire
brain in addition to the focal injuries observed in perioperative
imaging studies (Miller et al., 2007; Licht et al., 2009;
Limperopoulos et al., 2010,). We therefore interpret our findings
as the joint global result of delayed intrauterine brain develop-
ment, early brain injury and consecutively altered brain develop-
ment over a prolonged period of time. Our findings highlight the
importance of quantitative MRI measurements, as qualitative
visual neuroradiological assessment seems to underestimate the
extent of brain volume loss.
Brain volume reduction affects
neurodevelopmental outcome
The brain volume reduction observed in adolescent patients with
CHD is of clinical relevance, as global and regional brain volumes
correlated with neurodevelopmental functioning (Fig. 2 and
Table 3). This association is even more remarkable as patients with
overt lesions and worse neurodevelopmental outcome (von Rhein
et al., 2011) were excluded from our analyses. As hypothesized, we
showed an association between reduced total brain volume and white
matter volume and deficits in cognitive performance. Furthermore,
we found correlations between regional volumes (i.e. corpus callo-
sum, hippocampus and cerebellar volume) and cognitive abilities in
our patients with CHD, similar to studies in former preterm-born ado-
lescents (Martinussen et al., 2009; Northam et al., 2011).
The strong association between white matter reduction and out-
come is in agreement with diffusion-weighted imaging and functional
MRI studies that have shown parameters of long-range connectivity to
correlate with working memory (Nagy et al., 2004), intelligence
(Schmithorst et al., 2005), and language skills across development in
normally developing children and adolescents. The loss of white matter
could be (perhaps non-linearly) associated with less connected and
thus less efficient neuronal networks in the CHD patient group. If so,
there might only be a weak association between brain volume and
intelligence as long as white matter volume does not fall below a cer-
tain limit. However, an intrauterine delay in myelination (Miller et al.,
2007; Licht et al., 2009) could exacerbate functional impairments by a
reduction of synapses formation.
It would have been interesting to compare our results with
functional MRI data. As such measurements were not part of
our study, the regional distribution of correlating areas should be
interpreted cautiously. We assume they rather represent the areas
of the most prominent volume loss, and therefore show the stron-
gest correlations with functional outcomes. This does not neces-
sarily imply that they are functionally more relevant than other
regions. Nevertheless, we regard the regions associated with
Figure 3 Scatterplot of intelligence quotient versus total brain
volume (no CSF), plotted separately for controls and acyanotic
and cyanotic patients. Linear regression curves of controls
(R2 = 0.002), acyanotic (R2 = 0.233) and cyanotic heart disease
(R2 = 0.138).
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poor outcome in our study to be the indicators of a variety of
functionally relevant brain areas. This is also supported by the fact
that in the control group the association between total brain
volume and overall IQ was not present, and fewer correlations
between regional volumes and functional performance were
found. The fact that a significant relationship between structural
and functional findings were only detected in patients, but not in
controls, could have been because of a greater variability in the
volumes and neurodevelopment outcomes of the patients, thereby
leading to a greater power to detect a correlation. However, we
did not find such a difference: structural and functional results
were equally distributed in controls and patients (Fig. 2).
Therefore, it is conceivable that reduced brain volumes lead to
an impaired function, but it could also be that a common, third
factor could lead to both reduced functional and structural out-
comes, e.g. altered and delayed intrauterine brain development, as
has been shown by Miller et al. (2007).
Risk factors
In our study, adolescents with cyanotic CHD had the most pro-
nounced brain volume reductions. Adolescents with an acyanotic
CHD also showed a significant volume reduction compared with
control subjects; this was, however, less pronounced than in those
with cyanotic CHD. This finding broadens current knowledge of
how cardiac disease severity affects brain development and injury.
Surprisingly though, in contrast with the morphometric findings,
there was no difference in neurodevelopmental outcome between
patients with cyanotic and acyanotic heart disease. This may be
explained by the fact that environmental factors and compensa-
tory pathways may lead to similar functional results despite
reduced brain volumes. Another explanation might be that pa-
tients with cyanotic heart disease can rely on more localized net-
works instead of distributed networks, with comparable functional
outcome despite smaller brain volumes.
Besides CHD severity, no other independent clinical risk factor
predicted morphometric measures. This contrasts with a recent
publication reporting total bypass time, length of hospital stay,
and catheterization exposure to be significantly correlated with
structural abnormalities on MRI in adolescent patients with CHD
(Bellinger et al., 2011). Presumably, this depends greatly on the
variability of the patient sample and surgical methods applied. For
example, our patients had a variety of different cardiac diagnoses
and were operated at an older age than the cohort reported by
Bellinger et al. (2011), which consisted only of patients with a
d-transposition of the great arteries undergoing either deep hypo-
thermic cardiopulmonary arrest or low-flow cardiopulmonary
support.
Future perspective
Sixty years after the first successful cardiopulmonary bypass sur-
gery in an 18-year-old young adult, the surgical closure of an
atrial septal defect, a new patient population of adults with
CHD has evolved. Overall mortality has decreased to 55% in
most centres as a result of advances in the treatment of CHD,
leading to a continuously rising number of patients reaching
adulthood. Despite the low mortality rate, the most complex
types of cyanotic heart disease are still challenging, not only
with respect to their cardiological and cardio-surgical treatment,
but also regarding their long-term follow-up until adulthood: pre-
sumably, adults with CHD are at risk of a wide range of neuro-
developmental impairments with cognitive and motor deficits, and
many have difficulties with daily living skills, communication or
adaptive behaviour, as has been shown for adolescents with
CHD (Bellinger et al., 2003; Hovels-Gurich et al., 2006; Ballweg
et al., 2007; Majnemer et al., 2008; Snookes et al., 2010; von
Rhein et al., 2011). Therefore, adults with CHD require a multi-
dimensional medical attendance, which has to be provided not
only by paediatric and adult cardiologists, but also by neurologists
and neuropsychologists.
Limitations
Several limitations of our study have to be mentioned. Our cohort
does not include one single diagnosis of CHD but covers a wide
spectrum of diagnoses. Because of the rather small sample size,
conclusions for individual types of CHD cannot be drawn.
Furthermore, children with hypoplastic left heart syndrome were
not surgically treated in our institution in the late 1990s and thus
could not be included in this cohort. Therefore, our results most
likely underestimate the extent of long-term cerebral changes in
the population with CHD currently being treated. Furthermore, we
were not able to compare adolescent cerebral imaging findings to
neonatal imaging or preoperative clinical findings, thus limiting the
conclusions on timing of brain injury and intrauterine brain
growth.
Conclusion
We found a significant reduction of global and regional brain
volume in adolescent CHD patients without overt brain lesions
compared to healthy controls. Brain volume reduction was more
pronounced in patients with cyanotic heart disease. It correlated
significantly with neurodevelopmental performance, highlighting
the relevance of these widespread cortical and subcortical
volume reductions for cognitive outcome. Our findings provide
important new contributions to the understanding of the long-
term effects of brain injury in patients with CHD. Delayed brain
maturation at term and neonatal brain injury with its conse-
quences on brain development seem to persist into adolescence
and are functionally significant. Anatomically detected brain le-
sions seem to be only the tip of the iceberg, and even subtle
brain volume reduction can be functionally relevant.
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